432 related articles for article (PubMed ID: 29427283)
1. Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice.
Mani S; Sekar S; Barathidasan R; Manivasagam T; Thenmozhi AJ; Sevanan M; Chidambaram SB; Essa MM; Guillemin GJ; Sakharkar MK
Neurotox Res; 2018 Apr; 33(3):656-670. PubMed ID: 29427283
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of naringenin against MPTP-induced oxidative stress.
Sugumar M; Sevanan M; Sekar S
Int J Neurosci; 2019 Jun; 129(6):534-539. PubMed ID: 30433834
[TBL] [Abstract][Full Text] [Related]
4. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
5. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease.
Li XH; Dai CF; Chen L; Zhou WT; Han HL; Dong ZF
CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
9. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
Guo L; Li Y; Li W; Qiu J; Du J; Wang L; Zhang T
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1221-1231. PubMed ID: 36054693
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
Shi X; Chen YH; Liu H; Qu HD
Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
Atiq A; Lee HJ; Khan A; Kang MH; Rehman IU; Ahmad R; Tahir M; Ali J; Choe K; Park JS; Kim MO
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373089
[TBL] [Abstract][Full Text] [Related]
12. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
13. Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K/AKT signaling pathway in the MPTP-induced Parkinson's disease mouse.
Liu L; Jiang L; Zhang J; Ma Y; Wan M; Hu X; Yang L
Neuroreport; 2024 Feb; 35(3):175-184. PubMed ID: 38305108
[TBL] [Abstract][Full Text] [Related]
14. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
15. Counteracting neuroinflammation in experimental Parkinson's disease favors recovery of function: effects of Er-NPCs administration.
Carelli S; Giallongo T; Gombalova Z; Rey F; Gorio MCF; Mazza M; Di Giulio AM
J Neuroinflammation; 2018 Nov; 15(1):333. PubMed ID: 30501635
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective potential of plant derived parenchymal stem cells extract on environmental and genetic models of Parkinson disease through attenuation of oxidative stress and neuroinflammation.
Ishola IO; Oloyo AK; Olubodun-Obadun TG; Godswill OD; Omilabu SA; Adeyemi OO
Metab Brain Dis; 2023 Feb; 38(2):557-571. PubMed ID: 36401682
[TBL] [Abstract][Full Text] [Related]
18. Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Selvakumar GP; Janakiraman U; Essa MM; Justin Thenmozhi A; Manivasagam T
Brain Res; 2014 Oct; 1585():23-36. PubMed ID: 24657313
[TBL] [Abstract][Full Text] [Related]
19. Treadmill exercise alleviates motor deficits and improves mitochondrial import machinery in an MPTP-induced mouse model of Parkinson's disease.
Koo JH; Cho JY; Lee UB
Exp Gerontol; 2017 Mar; 89():20-29. PubMed ID: 28062370
[TBL] [Abstract][Full Text] [Related]
20. N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice.
Crupi R; Impellizzeri D; Cordaro M; Siracusa R; Casili G; Evangelista M; Cuzzocrea S
Mol Neurobiol; 2018 Nov; 55(11):8455-8472. PubMed ID: 29552727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
